Patent ID: 8221754

Claim:
An isolated anti-human α9 integrin antibody, wherein in the heavy-chain complementarity determining region (CDRH): CDRH1 is the amino acid sequence set forth in SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 or SEQ ID NO:41; CDRH2 is the amino acid sequence set forth in SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23 or SEQ ID NO:42; and CDRH3 is the amino acid sequence set forth in SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27 or SEQ ID NO:43, and wherein in the light-chain complementarity determining region (CDRL): CDRL1 is the amino acid sequence set forth in SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31 or SEQ ID NO:44; CDRL2 is the amino acid sequence set forth in SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35 or SEQ ID NO:45; and CDRL3 is the amino acid sequence set forth in SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID NO:39 or SEQ ID NO:46.